Badgley, Phelps & Bell’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $6.39M | Sell |
92,745
-462
| -0.5% | -$30.8K | 0.24% | 105 |
|
|
2021
Q1 | $6.02M | Sell |
93,207
-170
| -0.2% | -$11K | 0.25% | 102 |
|
|
2020
Q4 | $5.44M | Buy |
93,377
+358
| +0.4% | +$21.6K | 0.24% | 103 |
|
|
2020
Q3 | $5.88M | Buy |
93,019
+15
| +0% | +$1.04K | 0.29% | 98 |
|
|
2020
Q2 | $7.16M | Buy |
93,004
+232
| +0.3% | +$17.8K | 0.39% | 90 |
|
|
2020
Q1 | $6.94M | Sell |
92,772
-6,359
| -6% | -$439K | 0.46% | 79 |
|
|
2019
Q4 | $6.44M | Sell |
99,131
-1,170
| -1% | -$76.2K | 0.34% | 94 |
|
|
2019
Q3 | $6.36M | Sell |
100,301
-650
| -0.6% | -$42.5K | 0.36% | 92 |
|
|
2019
Q2 | $6.82M | Sell |
100,951
-350
| -0.3% | -$23K | 0.4% | 89 |
|
|
2019
Q1 | $6.58M | Sell |
101,301
-200
| -0.2% | -$13.3K | 0.4% | 91 |
|
|
2018
Q4 | $6.35M | Sell |
101,501
-449
| -0.4% | -$31.4K | 0.46% | 81 |
|
|
2018
Q3 | $7.87M | Sell |
101,950
-4,705
| -4% | -$355K | 0.48% | 90 |
|
|
2018
Q2 | $7.55M | Sell |
106,655
-1,172
| -1% | -$82.8K | 0.49% | 88 |
|
|
2018
Q1 | $8.13M | Sell |
107,827
-1,113
| -1% | -$88.5K | 0.54% | 85 |
|
|
2017
Q4 | $7.8M | Sell |
108,940
-98
| -0.1% | -$7.44K | 0.54% | 85 |
|
|
2017
Q3 | $8.83M | Buy |
109,038
+5,700
| +6% | +$436K | 0.65% | 70 |
|
|
2017
Q2 | $7.31M | Sell |
103,338
-113
| -0.1% | -$7.52K | 0.57% | 85 |
|
|
2017
Q1 | $7.03M | Sell |
103,451
-91,190
| -47% | -$6.41M | 0.57% | 90 |
|
|
2016
Q4 | $13.9M | Sell |
194,641
-7,343
| -4% | -$546K | 1.21% | 15 |
|
|
2016
Q3 | $16M | Sell |
201,984
-451
| -0.2% | -$36.6K | 1.41% | 12 |
|
|
2016
Q2 | $16.9M | Sell |
202,435
-2,353
| -1% | -$209K | 1.54% | 10 |
|
|
2016
Q1 | $18.8M | Sell |
204,788
-3,171
| -2% | -$286K | 1.77% | 6 |
|
|
2015
Q4 | $21M | Buy |
207,959
+6,979
| +3% | +$726K | 2.07% | 3 |
|
|
2015
Q3 | $19.7M | Sell |
200,980
-1,618
| -0.8% | -$180K | 2.05% | 4 |
|
|
2015
Q2 | $23.7M | Sell |
202,598
-992
| -0.5% | -$108K | 2.32% | 4 |
|
|
2015
Q1 | $20M | Sell |
203,590
-1,697
| -0.8% | -$172K | 1.96% | 5 |
|
|
2014
Q4 | $19.4M | Sell |
205,287
-1,907
| -0.9% | -$197K | 1.89% | 5 |
|
|
2014
Q3 | $22.1M | Sell |
207,194
-5,848
| -3% | -$573K | 2.18% | 4 |
|
|
2014
Q2 | $17.7M | Buy |
213,042
+17,081
| +9% | +$1.33M | 1.76% | 6 |
|
|
2014
Q1 | $13.9M | Buy |
195,961
+70,033
| +56% | +$5.49M | 1.43% | 8 |
|
|
2013
Q4 | $9.46M | Sell |
125,928
-70,418
| -36% | -$4.9M | 0.99% | 34 |
|
|
2013
Q3 | $12.3M | Buy |
196,346
+78,878
| +67% | +$4.71M | 1.39% | 11 |
|
|
2013
Q2 | $6.02M | Buy |
+117,468
| New | +$6.12M | 0.71% | 65 |
|
Other funds holding GILD
Badgley, Phelps & Bell's GILD Position: Q2 2021 in Review
Badgley, Phelps & Bell reduced its Gilead Sciences (GILD) stake by 0.5% in Q2 2021, selling an estimated $30.8K and leaving 92,745 shares worth $6.39M. The position accounts for 0.24% of the portfolio, ranked #105.
Badgley, Phelps & Bell first reported a position in GILD in Q2 2013 and has held it in 33 quarters since. The position peaked at $23.7M in Q2 2015. 1,545 funds tracked by Wall St. Rank hold GILD as of Q2 2021.
- Badgley, Phelps & Bell held 92,745 shares of Gilead Sciences worth $6.39M as of Q2 2021.
- Badgley, Phelps & Bell sold 462 Gilead Sciences shares in Q2 2021, an estimated $30.8K.
- Gilead Sciences made up 0.24% of Badgley, Phelps & Bell's portfolio in Q2 2021, its #105 holding.
- Badgley, Phelps & Bell first reported a position in Gilead Sciences in Q2 2013 and has held it in 33 quarters since.
- Badgley, Phelps & Bell's Gilead Sciences position peaked at $23.7M in Q2 2015.
- 1,545 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.
Based on Badgley, Phelps & Bell's 13F filing for Q2 2021, filed 28 Jul 2021.